The Chemours Company
CCFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
5,782
Cost of Revenue
4,631
Gross Profit
1,151
Gross Margin
19.9%
Operating Income
443
Operating Margin
7.7%
Net Income
86
Net Margin
1.5%
EPS (Basic)
$0.58
EPS (Diluted)
$0.57
EBITDA
692
EBITDA Margin
12.0%
2023
12/31/2023
Revenue
6,078
Cost of Revenue
4,772
Gross Profit
1,306
Gross Margin
21.5%
Operating Income
-123
Operating Margin
-2.0%
Net Income
-238
Net Margin
-3.9%
EPS (Basic)
$-1.60
EPS (Diluted)
$-1.60
EBITDA
197
EBITDA Margin
3.2%
2022
12/31/2022
Revenue
6,831
Cost of Revenue
5,215
Gross Profit
1,616
Gross Margin
23.7%
Operating Income
786
Operating Margin
11.5%
Net Income
578
Net Margin
8.5%
EPS (Basic)
$3.72
EPS (Diluted)
$3.65
EBITDA
1,195
EBITDA Margin
17.5%
2021
12/31/2021
Revenue
6,345
Cost of Revenue
4,964
Gross Profit
1,381
Gross Margin
21.8%
Operating Income
674
Operating Margin
10.6%
Net Income
608
Net Margin
9.6%
EPS (Basic)
$3.69
EPS (Diluted)
$3.60
EBITDA
1,178
EBITDA Margin
18.6%
2020
12/31/2020
Revenue
4,969
Cost of Revenue
3,902
Gross Profit
1,067
Gross Margin
21.5%
Operating Income
448
Operating Margin
9.0%
Net Income
219
Net Margin
4.4%
EPS (Basic)
$1.33
EPS (Diluted)
$1.32
EBITDA
767
EBITDA Margin
15.4%